BNP Paribas Asset Management
TNGX icon

BNP Paribas Asset Management’s Tango Therapeutics TNGX Stock Holding History

BNP Paribas Asset Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.9K Sell
904
-121
-12% -$1.68K ﹤0.01% 2055
2025
Q4 		$9K Buy
+1,025
New +$8.83K ﹤0.01% 2189

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

BNP Paribas Asset Management's TNGX Position: Q1 2026 in Review

BNP Paribas Asset Management reduced its Tango Therapeutics (TNGX) stake by 12% in Q1 2026, selling an estimated $1.68K and leaving 904 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2055.

BNP Paribas Asset Management first reported a position in TNGX in Q4 2025 and has held it in 2 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • BNP Paribas Asset Management held 904 shares of Tango Therapeutics worth $18.9K as of Q1 2026.
  • BNP Paribas Asset Management sold 121 Tango Therapeutics shares in Q1 2026, an estimated $1.68K.
  • Tango Therapeutics made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #2055 holding.
  • BNP Paribas Asset Management first reported a position in Tango Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.